Healthcare Realty downgraded by Analyst with a new price target
$HR
Real Estate Investment Trusts
Real Estate
Analyst downgraded Healthcare Realty from Overweight to Neutral and set a new price target of $19.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/2/2025 | $19.00 → $17.00 | Buy → Hold | Jefferies |
| 1/2/2025 | $18.00 → $16.00 | Neutral → Underperform | Wedbush |
| 12/20/2024 | $19.00 | Overweight → Neutral | Analyst |
| 7/30/2024 | $17.00 → $16.00 | Equal Weight → Underweight | Wells Fargo |
| 2/20/2024 | $19.00 → $15.00 | Buy → Hold | Stifel |
| 2/20/2024 | $19.00 → $15.00 | Outperform → Neutral | Wedbush |
| 1/30/2024 | $18.00 | Hold | Deutsche Bank |
| 10/24/2023 | $17.00 | Neutral → Buy | BTIG Research |
Jefferies downgraded Healthcare Realty from Buy to Hold and set a new price target of $17.00 from $19.00 previously
Wedbush downgraded Healthcare Realty from Neutral to Underperform and set a new price target of $16.00 from $18.00 previously
Analyst downgraded Healthcare Realty from Overweight to Neutral and set a new price target of $19.00